Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Compass Pathfinder Ltd. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This prosecution involves 1 distinct examiner and 1 distinct art unit. The alignment of 1 action with the identified art unit suggests a targeted filing strategy within this specific technical field. By operating within 1 art unit, the company maintains a narrow procedural footprint at the patent office. This structure allows the legal team to focus their resources on the requirements of a specific technical group within the Biotechnology & Pharmaceuticals area.
The busiest examiner for the portfolio is JACKSON, SHAWQUIA, who is currently handling 1 pending office action. This 1 action constitutes the entire pending workload for the company. With 1 examiner managing the only active office action, the prosecution process is currently centralized. For the practitioner, this means that the outcome of the current patent application relies on the review and feedback provided by JACKSON, SHAWQUIA. Understanding the specific preferences of this individual is the primary factor in the current prosecution strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JACKSON, SHAWQUIA | 1 | 78.0% | -3.4% |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18565565 | FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME | JACKSON, SHAWQUIA | 1626 | §112 | Non-Final OA | — | Pending | Nov 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCompass Pathfinder Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Shawquia Jackson has the most, with 1 of Compass Pathfinder Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
